13G filed by Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Hengrui Pharmaceuticals Co., Ltd. reported 7,420,091 BRVE shares, 8.2% of the class, as of 2026-09-30, in a 13G accepted by EDGAR 2026-11-09 11:02:30 UTC.
- Accession
- 0001104659-26-124063
- Filer
- CIK 2080343
- Filed
- 2026-11-09
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
Stake
- Subject
- BRVE · Braveheart Bio, Inc.
- Shares
- 7,420,091
- Percent of class
- 8.2%
- Event date
- 2026-09-30
How the shares relate across the reporting persons: one reporting person counts. The page shows the largest row.
Reporting persons
| Person | Type | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Aggregate | Percent |
|---|---|---|---|---|---|---|---|
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. | CO | 7,420,091 | 0 | 7,420,091 | 0 | 7,420,091 | 8.2% |